CD45: A critical regulator of signaling thresholds in immune cells

Annual Review of Immunology

Volumn 21, Issue , 2003, Pages 107-137

  Hermiston, Michelle L ^a,b   Xu, Zheng ^b   Weiss, Arthur ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alternative splicing; Autoimmunity; Dimerization; Protein tyrosine phosphatase

Indexed keywords

ANTINEOPLASTIC AGENT; CD45 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; ISOPROTEIN; MONOCLONAL ANTIBODY; PEPTIDE DERIVATIVE; PEROXYNITRITE; PHENANTHRENE DERIVATIVE; PHOSPHATASE; PHOSPHONIC ACID DERIVATIVE; PROTEIN KINASE P60; T LYMPHOCYTE RECEPTOR; TU 752; TYROSINE DERIVATIVE;

ALLERGIC DISEASE; ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; ANTIGEN FUNCTION; ANTIGEN STRUCTURE; ANTINEOPLASTIC ACTIVITY; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL MATURATION; CELL TYPE; CHOLESTASIS; DIMERIZATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG TARGETING; DRUG TOLERABILITY; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; GRAFT REJECTION; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; INFANT DISEASE; LEUKEMIA; MALNUTRITION; MULTIPLE MYELOMA; NONHUMAN; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; ANIMAL; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MOUSE; PHYSIOLOGY;

ALTERNATIVE SPLICING; ANIMALS; ANTIGENS, CD45; B-LYMPHOCYTES; GENE EXPRESSION REGULATION; HUMANS; MICE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0038815306     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.21.120601.140946     Document Type: Review

References (184)

1. Thomas ML. 1989. The leukocyte common antigen family. Annu. Rev. Immunol. 7:339-69
2. Trowbridge IS, Thomas ML. 1994. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu. Rev. Immunol. 12:85-116
3. Okumura M, Matthews RJ, Robb B, Litman GW, Bork P, Thomas ML. 1996. Comparison of CD45 extracellular domain sequences from divergent vertebrate species suggests the conservation of three fibronectin type III domains. J. Immunol. 157:1569-75
4. Sato T, Furukawa K, Autero M, Gahmberg CG, Kobata A. 1993. Structural study of the sugar chains of human leukocyte common antigen CD45. Biochemistry 32:12694-704
5. Furukawa K, Funakoshi Y, Autero M, Horejsi V, Kobata A, Gahmberg CG. 1998. Structural study of the O-linked sugar chains of human leukocyte tyrosine phosphatase CD45. Eur. J. Biochem. 251:288-94
6. Powell LD, Sgroi D, Sjoberg ER, Stamenkovic I, Varki A. 1993. Natural ligands of the B cell adhesion molecule CD22 beta carry N-linked oligosaccharides with alpha-2,6-linked sialic acids that are required for recognition. J. Biol. Chem. 268:7019-27
7. Uemura K, Yokota Y, Kozutsumi Y, Kawasaki T 1996. A unique CD45 glycoform recognized by the serum mannan-binding protein in immature thymocytes. J. Biol. Chem. 271:4581-84
8. Baldwin TA, Gogela-Spehar M, Ostergaard HL. 2000. Specific isoforms of the resident endoplasmic reticulum protein glucosidase II associate with the CD45 protein-tyrosine phosphatase via a lectin-like interaction. J. Biol. Chem. 275:32071-76
9. Baldwin TA, Ostergaard HL. 2001. Developmentally regulated changes in glucosidase II association with, and carbohydrate content of, the protein tyrosine phosphatase CD45. J. Immunol. 167:3829-35
10. Desai DM, Sap J, Silvennoinen O, Schlessinger J, Weiss A. 1994. The catalytic activity of the CD45 membrane proximal phosphatase domain is required for TCR signaling and regulation. EMBO J. 13:4002-10
11. Felberg J, Johnson P. 1998. Characterization of recombinant CD45 cytoplasmic domain proteins. Evidence for intramolecular and intermolecular interactions. J. Biol. Chem. 273:17839-45
12. Felberg J, Johnson P. 2000. Stable interdomain interaction within the cytoplasmic domain of CD45 increases enzyme stability. Biochem. Biophys. Res. Commun. 271:292-98
13. Hayami-Noumi K, Tsuchiya T, Moriyama Y, Noumi T 2000. Intra- and intermolecular interactions of the catalytic domains of human CD45 protein tyrosine phosphatase. FEBS Lett. 468:68-72
14. Wang Y, Guo W, Liang L, Esselman WJ. 1999. Phosphorylation of CD45 by casein kinase 2. Modulation of activity and mutational analysis. J. Biol. Chem. 274:7454-61
15. Greer SF, Wang Y, Raman C, Justement LB. 2001. CD45 function is regulated by an acidic 19-amino acid insert in domain II that serves as a binding and phosphoacceptor site for casein kinase 2. J. Immunol. 166:7208-18
16. Volarevic S, Niklinska BB, Burns CM, June CH, Weissman AM, Ashwell JD. 1993. Regulation of TCR signaling by CD45 lacking transmembrane and extracellular domains. Science 260:541-44
17. Hovis RR, Donovan JA, Musci MA, Motto DG, Goldman FD, et al. 1993. Rescue of signaling by a chimeric protein containing the cytoplasmic domain of CD45. Science 260:544-46
18. Fukuhara K, Okumura M, Shiono H, Inoue M, Kadota Y, et al. 2002. A study on CD45 isoform expression during T-cell development and selection events in the human thymus. Hum. Immunol. 63:394-404
19. Johnson SA, Rozzo SJ, Cambier JC. 2002. Aging-dependent exclusion of antigen-inexperienced cells from the peripheral B cell repertoire. J. Immunol. 168:5014-23
20. Virts E, Barritt D, Raschke WC. 1998. Expression of CD45 isoforms lacking exons 7, 8 and 10. Mol. Immunol. 35:167-76
21. Wallace VA, Penninger JM, Kishihara K, Timms E, Shahinian A, et al. 1997. Alterations in the level of CD45 surface expression affect the outcome of thymic selection. J. Immunol. 158:3205-14
22. Timon M, Beverley PC. 2001. Structural and functional analysis of the human CD45 gene (PTPRC) upstream region: evidence for a functional promoter within the first intron of the gene. Immunology 102:180-89
23. Saga Y, Tung J-S, Shen F-W, Boyse EA. 1987. Alternative use of 5′ exons in the specification of Ly-5 isoforms distinguishing hematopoietic cell lineages. Proc. Natl. Acad. Sci. USA 84:5364-68
24. Hall LR, Streuli M, Schlossman SF, Saito H. 1988. Complete exon-intron organization of the human leukocyte common antigen (CD45) gene. J. Immunol. 141:2781-87
25. Anson DS, Occhiodoro T. 1994. Transcriptional activity of the CD45 gene promoter in retroviral vector constructs. Biochim. Biophys. Acta 1219:81-88
26. Virts EL, Raschke WC. 2001. The role of intron sequences in high level expression from CD45 cDNA constructs. J. Biol. Chem. 276:19913-20
27. Kishihara K, Penninger J, Wallace VA, Kundig TM, Kawai K, et al. 1993. Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice. Cell 74:143-56
28. Anderson KL, Nelson SL, Perkin HB, Smith KA, Klemsz MJ, Torbett BE. 2001. PU. 1 is a lineage-specific regulator of tyrosine phosphatase CD45. J. Biol. Chem. 276:7637-42
29. Anderson KL, Smith KA, Conners K, McKercher SR, Maki RA, Torbett BE. 1998. Myeloid development is selectively disrupted in PU. 1 null mice. Blood 91:3702-10
30. Lynch KW, Weiss A. 2000. A model system for activation-induced alternative splicing of CD45 pre-mRNA in T cells implicates PKC and Ras. Mol. Cell. Biol. 20:70-80
31. Birkeland ML, Johnson P, Trowbridge IS, Pure E. 1989. Changes in CD45 isoform expression accompany antigen-induced murine T cell activation. Proc. Natl. Acad. Sci. USA 86:6734-38
32. Deans JP, Boyd AW, Pilarski M. 1989. Transitions from high to low molecular weight isoforms of CD45 (T200) involve rapid activation of alternate mRNA splicing and slow turnover of surface CD45R. J. Immunol. 143:1233-38
33. Tchilian EZ, Dawes R, Ramaley PA, Whitworth JA, Yuldasheva N, et al. 2002. A CD45 polymorphism associated with abnormal splicing is absent in African populations. Immunogenetics 53:980-83
34. Thude H, Hundreiser J, Wonigeit K, Schwinzer R. 1995. A point mutation in the CD45 gene associated with defective splicing of exon A. Eur. J. Immunol. 25:2101-6
35. Zilch CF, Walker AM, Timon M, Goff LK, Wallace DL, Beverley PC. 1998. A point mutation within CD45 exon A is the cause of variant CD45RA splicing in humans. Eur. J. Immunol. 28:22-29
36. Lynch KW, Weiss A. 2001. A CD45 polymorphism associated with multiple sclerosis disrupts an exonic splicing silencer. J. Biol. Chem. 276:24341-47
37. Jacobsen M, Schweer D, Ziegler A, Gaber R, Schock S, et al. 2000. A point mutation in PTPRC is associated with the development of multiple sclerosis. Nat. Genet. 26:495-99
38. Jacobsen M, Hoffmann S, Cepok S, Stei S, Ziegler A, et al. 2002. A novel mutation in PTPRC interferes with splicing and alters the structure of the human CD45 molecule. Immunogenetics 54:158-63
39. Vorechovsky I, Kralovicova J, Tchilian E, Masterman T, Zhang Z, et al. 2001. Does 77C → G in PTPRC modify autoimmune disorders linked to the major histocompatibility locus? Nat. Genet. 29:22-23
40. Barcellos LF, Caillier S, Dragone L, Elder M, Vittinghoff E, et al. 2001. PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patients. Nat. Genet. 29:23-24
41. Miterski B, Sindern E, Haupts M, Schimrigk S, Epplen JT. 2002. PTPRC (CD45) is not associated with multiple sclerosis in a large cohort of German patients. BMC Med. Genet. 3:3
42. Wood JP, Bieda K, Segni M, Herwig J, Krause M, et al. 2002. CD45 exon 4 point mutation does not confer susceptibility to type 1 diabetes mellitus or Graves' disease. Eur. J. Immunogenet. 29:73-74
43. Mee PJ, Turner M, Basson MA, Costello PS, Zamoyska R, Tybulewicz VL. 1999. Greatly reduced efficiency of both positive and negative selection of thymocytes in CD45 tyrosine phosphatase-deficient mice. Eur. J. Immunol. 29:2923-33
44. Majeti R, Xu Z, Parslow TG, Olson JL, Daikh DI, et al. 2000. An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell 103:1059-70
45. Subra JF, Cautain B, Xystrakis E, Mas M, Lagrange D, et al. 2001. The balance between CD45RChigh and CD45RClow CD4 T cells in rats is intrinsic to bone marrow-derived cells and is genetically controlled. J. Immunol. 166:2944-52
46. ten Dam GB, Zilch CF, Wallace D, Wieringa B, Beverley PC, et al. 2000. Regulation of alternative splicing of CD45 by antagonistic effects of SR protein splicing factors. J. Immunol. 164:5287-95
47. Lemaire R, Winne A, Sarkissian M, Lafyatis R. 1999. SF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activation. Eur. J. Immunol. 29:823-37
48. Sarkissian M, Winne A, Lafyatis R. 1996. The mammalian homolog of suppressor-of-white-apricot regulates alternative mRNA splicing of CD45 exon 4 and fibronectin IIICS. J. Biol. Chem. 271:31106-14
49. Wang HY, Xu X, Ding JH, Bermingham JR Jr, Fu XD. 2001. SC35 plays a role in T cell development and alternative splicing of CD45. Mol. Cell. 7:331-42
50. Koretzky GA, Picus J, Thomas ML, Weiss A. 1990. Tyrosine phosphatase CD45 is essential for coupling T cell antigen receptor to the phosphatidylinositol pathway. Nature 346:66-68
51. Pingel JT, Thomas ML. 1989. Evidence that the leukocyte-common antigen is required for antigen-induced T lymphocyte proliferation. Cell 58:1055-65
52. Kung C, Pingel JT, Heikinheimo M, Klemola T, Varkila K, et al. 2000. Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. Nat. Med. 6:343-45
53. Tchilian EZ, Wallace DL, Wells RS, Flower DR, Morgan G, Beverley PC. 2001. A deletion in the gene encoding the CD45 antigen in a patient with SCID. J. Immunol. 166:1308-13
54. + thymocytes, and in B cell maturation. J. Exp. Med. 183:1707-18
55. Ong CJ, Dutz JP, Chui D, Teh HS, Marth JD. 1997. CD45 enhances positive selection and is expressed at a high level in large, cycling, positively selected CD4+CD8+ thymocytes. Immunology 91:95-103
56. Sato T, Kishihara K, Mak TW, Habu S. 1998. Beta-selection of immature thymocytes is less dependent on CD45 tyrosinephosphatase. Immunol. Lett. 64:133-38
57. Stone JD, Conroy LA, Byth KF, Hederer RA, Howlett S, et al. 1997. Aberrant TCR-mediated signaling in CD45-null thymocytes involves dysfunctional regulation of Lck, Fyn, TCR-ζ, and ZAP-70. J. Immunol. 158:5773-82
58. Trop S, Charron J, Arguin C, Lesage S, Hugo P. 2000. Thymic selection generates T cells expressing self-reactive TCRs in the absence of CD45. J. Immunol. 165:3073-79
59. Latour S, Veillette A. 2001. Proximal protein tyrosine kinases in immunoreceptor signaling. Curr. Opin. Immunol. 13:299-306
60. Kane LP, Lin J. Weiss A. 2002. It's all Rel-ative: NF-kappaB and CD28 costimulation of T-cell activation. Trends. Immunol. 23:413-20
61. Ashwell JD, D'Oro U. 1999. CD45 and Src-family kinases: and now for something completely different. Immunol. Today 20:412-16
62. Thomas ML, Brown EJ. 1999. Positive and negative regulation of Src-family membrane kinases by CD45. Immunol. Today 20:406-11
63. Alexander DR. 2000. The CD45 tyrosine phosphatase: a positive and negative regulator of immune cell function. Semin. Immunol. 12:349-59
64. Hermiston ML, Xu Z, Majeti R, Weiss A. 2002. Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases. J. Clin. Invest. 109:9-14
65. Young MA, Gonfloni S, Superti-Furga G, Roux B, Kuriyan J. 2001. Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by C-terminal tyrosine phosphorylation. Cell 105:115-26
66. Cahir McFarland ED, Hurley TR, Pingel JT, Sefton BM, Shaw A, Thomas ML. 1993. Correlation between Src family member regulation by the protein-tyrosine-phosphatase CD45 and transmembrane signaling through the T-cell receptor. Proc. Natl. Acad. Sci. USA 90:1402-6
67. Sieh M, Bolen JB, Weiss A. 1993. CD45 specifically modulates binding of Lck to a phosphopeptide encompassing the negative regulatory tyrosine of Lck. EMBO J. 12:315-22
68. Seavitt JR, White LS, Murphy KM, Loh DY, Perlmutter RM, Thomas ML. 1999. Expression of the p56(lck) Y505F mutation in CD45-deficient mice rescues thymocyte development. Mol. Cell. Biol. 19:4200-8
69. Pingel S, Baker M, Turner M, Holmes N, Alexander DR. 1999. The CD45 tyrosine phosphatase regulates CD3-induced signal transduction and T cell development in recombinase-deficient mice: restoration of pre-TCR function by active 56(lck). Eur. J. Immunol. 29:2376-84
70. Burns CM, Sakaguchi K, Appella E, Ashwell JD. 1994. CD45 regulation of tyrosine phosphorylation and enzyme activity of src family kinases. J. Biol. Chem. 269:13594-600
71. D'Oro U, Ashwell JD. 1999. Cutting edge: the CD45 tyrosine phosphatase is an inhibitor of Lck activity in thymocytes. J. Immunol. 162:1879-83
72. Shenoi H, Seavitt J, Zheleznyak A, Thomas ML, Brown EJ. 1999. Regulation of integrin-mediated T cell adhesion by the transmembrane protein tyrosine phosphatase CD45. J. Immunol. 162:7120-27
73. Roach T, Slater S, Koval M, White L, McFarland EC, et al. 1997. CD45 regulates Src family member kinase activity associated with macrophage integrinmediated adhesion. Curr. Biol. 7:408-17
74. Baker M, Gamble J, Tooze R, Higgins D, Yang FT, et al. 2000. Development of T-leukaemias in CD45 tyrosine phosphatase-deficient mutatnt lck mice. EMBO J. 19:4644-54
75. Dustin ML. 2002. Membrane domains and the immunological synapse: keeping T cells resting and ready. J. Clin. Invest. 109:155-60
76. Irie-Sasaki J, Sasaki T, Matsumoto W, Opavsky A, Cheng M, et al. 2001. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signaling. Nature 409:349-54
77. Penninger JM, Irie-Sasaki J, Sasaki T, Oliveira-dos-Santos AJ. 2001. CD45: new jobs for an old acquaintance. Nat. Immunol. 2:389-96
78. Yamada T, Zhu DC, Saxon A, Zhang K. 2002. CD45 controls IL-4-mediated IgE class switch recombination in human B cell through its function as a Janus kinase phosphatase. J. Biol. Chem. 277:28830-35
79. Liu P, Aitken K, Kong YY, Opavsky MA, Martino T, et al. 2000. The tyrosine kinase p56lckis essential in coxsackievirus B3-mediated heart disease. Nat. Med. 6:429-34
80. Mustelin T, Williams S, Tailor P, Couture C, Zenner G, et al. 1995. Regulation of the p70zap tyrosine protein kinase in T cells by the CD45 phosphotyrosine phosphatase. Eur. J. Immunol. 25:942-46
81. Furukawa T, Itoh M, Krueger NX, Streuli M, Saito H. 1994. Specific interaction of the CD45-protein tyrosine phosphatase with tyrosine phosphorylated CD3 ζ chain. Proc. Natl. Acad. Sci. USA 91:10928-32
82. Conroy LA, Stone JD, Frearson JA, Byth KF, Howlett S, et al. 1997. Tyrosine phosphatases in T-cell development and signalling. Biochem. Soc. Trans. 25:445-51
83. Fortin M, Steff AM, Felberg J, Ding L, Schraven B, et al. 2002. Apoptosis mediated through CD45 is independent of its phosphatase activity and association with leukocyte phosphatase-associated phosphoprotein. J. Immunol. 168:6084-89
84. Bleesing JJ, Brown MR, Dale JK, Straus SE, Lenardo MJ, et al. 2001. TcR-alpha/beta(+)CD4(-)CD8(-)T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis. Clin. Immunol. 100:314-24
85. Hehner SP, Hofmann TG, Droge W, Schmitz ML. 1999. Inhibition of tyrosine phosphatases induces apoptosis independent from the CD95 system. Cell Death Differ. 6:833-41
86. Schraven B, Peter ME. 1995. APO-1 (CD95)-mediated apoptosis in Jurkat cells does not involve src kinases or CD45. FEBS Lett. 368:491-94
87. Brooks WP, Lynes MA. 2001. Effects of hemizygous CD45 expression in the autoimmune Fas1(gld/gld) syndrome. Cell Immunol. 212:24-34
88. Trowbridge IS. 1991. CD45: A prototype for transmembrane protein tyrosine phosphatases. J. Biol. Chem. 266:23517-20
89. Novak TJ, Farber D, Leitenberg D, Hong SC, Johnson P, Bottomly K. 1994. Isoforms of the transmembrane tyrosine phosphatase CD45 differentially affect T cell recognition. Immunity 1:109-19
90. Onodera H, Motto DG, Koretzky GA, Rothstein DM. 1996. Differential regulation of activation-induced tyrosine phosphorylation and recruitment of SLP76 to Vav by distinct isoforms of the CD45 protein-tyrosine phosphatase. J. Biol. Chem. 271:22225-30
91. McKenney DW, Onodera H, Gorman L, Mimura T, Rothstein DM. 1995. Distinct isoforms of the CD45 protein-tyrosine phosphatase differentially regulate interleukin 2 secretion and activation signal pathways involving Vav in T cells. J. Biol. Chem. 270:24949-54
92. Dornan S, Sebestyen Z, Gamble J, Nagy P, Bodnar A, et al. 2002. Differential association of CD45 isoforms with CD4 and CD8 regulates the actions of specific pools of p56lck tyrosine kinase in T cell antigen receptor signal transduction. J. Biol. Chem. 277:1912-18
93. Chui D, Ong CJ, Johnson P, Teh HS, Marth JD. 1994. Specific CD45 isoforms differentially regulate T cell receptor signaling. EMBO J. 13:798-807
94. Leitenberg D, Novak TJ, Farber D, Smith BR, Bottomly K. 1996. The extracellular domain of CD45 controls association with the CD4-T cell receptor complex and the response to antigen-specific stimulation. J. Exp. Med. 183:249-59
95. Kozieradzki I, Kundig T, Kishihara K, Ong CJ, Chiu D, et al. 1997. T cell development in mice expressing splice variants of the protein tyrosine phosphatase CD45. J. Immunol. 158:3130-39
96. Czyzyk J, Leitenberg D, Taylor T, Bottomly K. 2000. Combinatorial effect of T-cell receptor ligation and CD45 isoform expression on the signaling contribution of the small GTPases Ras and Rap1. Mol. Cell. Biol. 20:8740-47
97. DeFranco AL. 2000. B-cell activation 2000. Immunol. Rev. 176:5-9
98. DeFranco AL, Chan VW, Lowell CA. 1998. Positive and negative roles of the tyrosine kinase Lyn in B cell function. Semin. Immunol. 10:299-307
99. Benatar T, Carsetti R, Furlonger C, Kamalia N, Mak TW, Paige CJ. 1996. Immunoglobulin-mediated signal transduction in B cells from CD45-deficient mice. J. Exp. Med. 183:329-34
100. Kong YY, Kishihara K, Sumichika H, Nakamura T, Kaneko M, Nomoto K. 1995. Differential requirements of CD45 for lymphocyte development and function. Eur. J. Immunol. 25:3431-36
101. Cyster JG, Healy JI, Kishihara K, Mak TW, Thomas ML, Goodnow CC. 1996. Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD45. Nature 381:325-28
102. Pani G, Siminovitch KA, Paige CJ. 1997. The motheaten mutation rescues B cell signaling and development in CD45- deficient mice. J. Exp. Med. 186:581-88
103. Justement LB, Campbell KS, Chien NC, Cambier JC. 1991. Regulation of B cell antigen receptor signal transduction and phosphorylation by CD45. Science 252:1839-42
104. Pao LI, Cambier JC. 1997. Syk, but not Lyn, recruitment to B cell antigen receptor and activation following stimulation of CD45 B cells. J. Immunol. 158:2663-69
105. Pao LI, Bedzyk WD, Persin C, Cambier JC. 1997. Molecular targets of CD45 in B cell antigen receptor signal transduction. J. Immunol. 158:1116-24
106. Crreer SE Justement LB. 1999. CD45 regulates tyrosine phosphorylation of CD22 and its association with the protein tyrosine phosphatase SHP-1. J. Immunol. 162:5278-86
107. Yanagi S, Sugawara H, Kurosaki M, Sabe H, Yamamura H, Kurosaki T. 1996. CD45 modulates phosphorylation of both autophosphorylation and negative regulatory tyrosines of Lyn in B cells. J. Biol. Chem. 271:30487-92
108. Ogimoto M, Katagiri T, Mashima K, Hasegawa K, Mizuno K, Yakura H. 1995. Antigen receptor-initiated growth inhibition is blocked in CD45-loss variants of a mature B lymphoma, with limited effects on apoptosis. Eur. J. Immunol. 25:2265-71
109. Ogimoto M, Arimura Y, Katagiri T, Mitomo K, Woodgett JR, et al. 2001. Opposing regulation of B cell receptor-induced activation of mitogen-activated protein kinases by CD45. FEBS Lett. 490:97-101
110. Katagiri T, Ogimoto M, Hasegawa K, Arimura Y, Mitomo K, et al. 1999. CD45 negatively regulates lyn activity by dephosphorylating both positive and negative regulatory tyrosine residues in immature B cells. J. Immunol. 163:1321-26
111. Katagiri T, Ogimoto M, Hasegawa K, Mizuno K, Yakura H. 1995. Selective regulation of Lyn tyrosine kinase by CD45 in immature B cells. J. Biol. Chem. 270:27987-90
112. Berger SA, Mak TW, Paige CJ. 1994. Leukocyte common antigen (CD45) is required for immunoglobulin E-mediated degranulation of mast cells. J. Exp. Med. 180:471-76
113. Gatewood B, Joe J, Zigmond SH. 1991. CD45 is not involved in the processing of spatial information required for chemotaxis. J. Immunol. 147:243-46
114. Harvath L, Balke JA, Christiansen NP, Russell AA, Skubitz KM. 1991. Selected antibodies to leukocyte common antigen (CD45) inhibit human neutrophil chemotaxis. J. Immunol. 146:949-57
115. Kuijpers TW, Hoogerwerf M, Roos D. 1992. Neutrophil migration across monolayers of resting or cytokine-activated endothelial cells. Role of intracellular calcium changes and fusion of specific granules with the plasma membrane. J. Immunol. 148:72-77
116. Fialkow L, Chan CK, Downey GP. 1997. Inhibition of CD45 during neutrophil activation. J. Immunol. 158:5409-17
117. Liles WC, Ledbetter JA, Waltersdorph AW, Klebanoff SJ. 1995. Cross-linking of CD45 enhances activation of the respiratory burst in response to specific stimuli in human phagocytes. J. Immunol. 155:2175-84
118. Mitchell GB, Khandaker MH, Rahimpour R, Xu L, Lazarovits AI, et al. 1999. CD45 modulation of CXCR1 and CXCR2 in human polymorphonuclear leukocytes. Eur. J. Immunol. 29:1467-76
119. Stamenkovic I, Sgroi D, Aruffo A, Sy MS, Anderson T. 1991. The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and alpha 2-6 sialyltransferase, CD75, on B cells. Cell 66:1133-44
120. Walzel H, Schulz U, Neels P, Brock J. 1999. Galectin-1, a natural ligand for the receptor-type protein tyrosine phosphatase CD45. Immunol. Lett. 67:193-202
121. Pace KE, Lee C, Stewart PL, Baum LG. 1999. Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. J. Immunol. 163:3801-11
122. Pace KE, Hahn HP, Pang MB, Nguyen JT, Baum LG. 2000. Cutting edge: CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death. J. Immunol. 165:2331-34
123. Desai DM, Sap J, Schlessinger J, Weiss A. 1993. Ligand-mediated negative regulation of a chimeric transmembrane receptor tyrosine phosphatase. Cell 73:541-54
124. Bilwes AM, den Hertog J, Hunter T, Noel JP. 1996. Structural basis for inhibition of receptor protein-tyrosine phosphatase-α by dimerization. Nature 382:555-59
125. Majeti R, Bilwes AM, Noel JP, Hunter T, Weiss A. 1998. Dimerization-induced inhibition of receptor protein tyrosine phosphatase function through an inhibitory wedge. Science 279:88-91
126. Takeda A, Wu JJ, Maizel AL. 1992. Evidence for monomeric and dimeric forms of CD45 associated with a 30-kDa phosphorylated protein. J. Biol. Chem. 267:16651-59
127. Symons A, Willis AC, Barclay AN. 1999. Domain organization of the extracellular region of CD45. Protein Eng. 12:885-92
128. Xu Z, Weiss A. 2002. Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms. Nat. Immunol. 3:764-71
129. Farber DL, Acuto O, Bottomly K. 1997. Differential T cell receptor-mediated signaling in naive and memory CD4 T cells. Eur. J. Immunol. 27:2094-101
130. Hall SR, Heffernan BM, Thompson NT, Rowan WC. 1999. CD4+ CD45RA+ and CD4+ CD45RO+ T cells differ in their TCR-associated signaling responses. Eur. J. Immunol. 29:2098-106
131. Mittler RS, Rankin BM, Kiener PA. 1991. Physical associations between CD45 and CD4 or CD8 occur as late activation events in antigen receptorstimulated human T cells. J. Immunol. 147:3434-40
132. Minami Y, Stafford FJ, LippincottSchwartz J, Yuan LC, Klausner RD. 1991. Novel redistribution of an intracellular pool of CD45 accompanies T cell activation. J. Biol. Chem. 266:9222-30
133. Pulido R, Lacal P, Mollinedo F, Sanchez-Madrid F. 1989. Biochemical and antigenic characterization of CD45 polypeptides expressed on plasma membrane and internal granules of human neutrophils. FEBS Lett. 249:337-42
134. Patterson WP, Caldwell CW, Yesus YW. 1993. In vivo upregulation of CD45RA in neutrophils of acutely infected patients. Clin. Immunol. Immunopathol. 68:35-40
135. Caldwell CW, Patterson WP, Yesus YW. 1991. Translocation of CD45RA in neutrophils. J. Leukoc. Biol. 49:317-28
136. Caldwell CW, Patterson WP, Toalson BD, Yesus YW. 1991. Surface and cytoplasmic expression of CD45 antigen isoforms in normal and malignant myeloid cell differentiation. Am. J. Clin. Pathol. 95:180-87
137. Rodgers W, Rose JK. 1996. Exclusion of CD45 inhibits activity of p56(lck) associated with glycolipid-enriched membrane domains. J. Cell Biol. 135:1515-23
138. Xavier R, Brennan T, Qingqin L, McCormack C, Seed B. 1988. Membrane compartmentation is required for efficient T cell activation. Immunity 8:723-32
139. Pierce S. 2002. Lipid rafts and B-cell activation. Mat. Rev. Immunol. 2:96-105
140. Montixi C, Langlet C, Bernard AM, Thimonier J, Dubois C, et al. 1998. Engagement of T cell receptor triggers its recruitment to low-density detergentinsoluble membrane domains. EMBO J. 17:5334-48
141. Ilangumaran S, Arni S, van Echten-Deckert G, Borisch B, Hoessli DC. 1999. Microdomain-dependent regulation of Lck and Fyn protein-tyrosine kinases in T lymphocyte plasma membranes. Mol. Biol. Cell. 10:891-905
142. Parolini I, Sargiacomo M, Lisanti MP, Peschle C. 1996. Signal transduction and glycophosphatidylinositol-linked proteins (lyn, lck, CD4, CD45, G proteins, and CD55) selectively localize in Triton-insoluble plasma membrane domains of human leukemic cell lines and normal granulocytes. Blood 87:3783-94
143. Shaw AS, Dustin ML. 1997. Making the T cell receptor go the distance: a topological view of T cell activation. Immunity 6:361-69
144. Leupin O, Zaru R, Laroche T, Muller S, Valitutti S. 2000. Exclusion of CD45 from the T-cell receptor signaling area in antigen-stimulated T lymphocytes. Curr. Biol. 10:277-80
145. Sperling AI, Sedy JR, Manjunath N, Kupfer A, Ardman B, Burkhardt JK. 1998. TCR signaling induces selective exclusion of CD43 from the T cell-antigen-presenting cell contact site. J. Immunol. 161:6459-62
146. Johnson KG, Bromley SK, Dustin ML, Thomas NL. 2000. A supramolecular basis for CD45 tyrosine phosphatase regulation in sustained T cell activation. Proc. Natl. Acad. Sci. USA 97:10138-43
147. Kitamura K, Maiti A, Ng DH, Johnson P, Maizel AL, Takeda A. 1995. Characterization of the interaction between CD45 and CD45-AP. J. Biol. Chem. 270:21151-57
148. Cahir McFarland ED, Thomas ML. 1995. CD45 protein-tyrosine phosphatase associated with the WW domaincontaining protein, CD45AP, through the transmembrane region. J. Biol. Chem. 270:28103-7
149. Schraven B, Schoenhaut D, Bruyns E, Koretzky G, Eckerskorn C, et al. 1994. LPAP, a novel 32-kDa phosphoprotein that interacts with CD45 in human lymphocytes. J. Biol. Chem. 269:29102-11
150. Kung C, Okumura M, Seavitt JR, Noll ME, White LS, et al. 1999. CD45-associated protein is not essential for the regulation of antigen receptor-mediated signal transduction. Eur. J. Immunol. 29:3951-55
151. Ding I, Bruyns E, Li P, Magada D, Paskind M, et al. 1999. Biochemical and functional analysis of mice deficient in expression of the CD45-associated phosphoprotein LPAP. Eur. J. Immunol. 29:3956-61
152. Matsuda A, Motoya S, Kimura S, Mcinnis R, Maizel AL, Takeda A. 1998. Disruption of lymphocyte function and signaling in CD45-associated protein-null mice. J. Exp. Med. 187:1863-70
153. Herold C, Elhabazi A, Bismuth G, Bensussan A, Boumsell L. 1996. CD100 is associated with CD45 at the surface of human T lymphocytes. Role in T cell homotypic adhesion. J. Immunol. 157:5262-68
154. Petricoin EF, Ito S, Williams BL, Audet S, Stancato LF, et al. 1997. Antiproliferative action of interferon-a requires components of T-cell-receptor signalling. Nature 390:629-32
155. Bourguignon LYW, Suchard SJ, Nagpal ML, Glenney JR. 1985. A T-lymphoma transmembrane glycoprotein (gp 180) is linked to the cytoskeletal protein, fodrin. J. Cell Biol. 101:477-87
156. Lokeshwar VB, Bourguignon LYW. 1992. Tyrosine phosphatase activity of lymphoma CD45 (GP180) is regulated by a direct interaction with the cytoskeleton. J. Biol. Chem. 267:21,551-57
157. Wu L, Fu J, Shen SH. 2002. SKAP55 coupled with CD45 positively regulates T-cell receptor-mediated gene transcription. Mol. Cell. Biol. 22:2673-86
158. Dianzani U, Luqman M, Rojo J, Yagi J, Baron JL, et al. 1990. Molecular associations on the T cell surface correlate with immunological memory. Eur. J. Immunol. 20:2249-57
159. Leitenberg D, Boutin Y, Lu DD, Bottomly K. 1999. Biochemical association of CD45 with the T cell receptor complex: regulation by CD45 isoform and during T cell activation. Immunity 10:701-11
160. Kang S, Liao P, Gage DA, Esselman J. 1997. Identification of in vivo phosphorylation sites of CD45 protein-tyrosine phosphatase in 70Z/3.12 cells. J. Biol. Chem. 272:11588-96
161. Autero M, Saharinen J, Pessa-Morikawa T, Soula-Rothhut M, Oetken C, et al. 1994. Tyrosine phosphorylation of CD45 phosphotyrosine phosphatase by p50csk kinase creates a binding site for p56lck tyrosine kinase and activates the phosphatase. Mol. Cell. Biol. 14:1308-21
162. Stover DR, Walsh KA. 1994. Proteintyrosine phosphatase activity of CD45 is activated by sequential phosphorylation by two kinases. Mol. Cell. Biol. 14:5523-32
163. Tan J, Town T, Mori T, Wu Y, Saxe M, et al. 2000. CD45 opposes betaamyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase. J. Neurosci. 20:7587-94
164. Takeuchi T, Pang M, Amano K, Koide J, Abe T. 1997. Reduced protein tyrosine phosphatase (PTPase) activity of CD45 on peripheral blood lymphocytes in patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 109:20-26
165. Huck S, Le Corre R, Youinou P, Zouali M. 2001. Expression of B cell receptor-associated signaling molecules in human lupus. Autoimmunity 33:213-24
166. Blasini AM, Alonzo E, Chacon R, Riera R, Stekman IL, Rodriguez MA. 1998. Abnormal pattern of tyrosine phosphorylation in unstimulated peripheral blood T lymphocytes from patients with systemic lupus erythematosus. Lupus 7:515-23
167. Mahmoud MS, Ishikawa H, Fujii R, Kawano MM. 1998. Induction of CD45 expression and proliferation in U-266 myeloma cell line by interleukin-6. Blood 92:3887-97
168. Ishikawa H, Mahmoud MS, Fujii R, Abroun S, Kawano MM. 2000. Proliferation of immature myeloma cells by interleukin-6 is associated with CD45 expression in human multiple myeloma. Leukoc. Lymphoma 39:51-55
169. Ishikawa H, Tsuyama N, Abroun S, Liu S, Li FJ, et al. 2002. Requirements of src family kinase activity associated with CD45 for myeloma cell proliferation by interleukin-6. Blood 99:2172-78
170. Roederer M, Raju PA, Mitra DK, Herzenberg LA. 1997. HIV does not replicate in naive CD4 T cells stimulated with CD3/CD28. J. Clin. Invest. 99:1555-64
171. Spina CA, Prince HE, Richman DD. 1997. Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro. J. Clin. Invest. 99:1774-85
172. Cayota A, Vuillier F, Scott-Algara D, Feuillie V, Dighiero G. 1993. Differential requirements for HIV-1 replication in naive and memory CD4 T cells from asymptomatic HIV-1 seropositive carders and AIDS patients. Clin. Exp. Immunol. 91:241-48
173. Woods TC, Roberts BD, Butera ST, Folks TM. 1997. Loss of inducible virus in CD45RA naive cells after human immunodeficiency virus-1 entry accounts for preferential viral replication in CD45RO memory cells. Blood 89:1635-41
174. Helbert MR, Walter J, L'Age J, Beverley PC. 1997. HIV infection of CD45RA+ and CD45RO+ CD4+ T cells. Clin. Exp. Immunol. 107:300-5
175. Barbeau B, Robichaud GA, Fortin JF, Tremblay MJ. 2001. Negative regulation of the NFAT1 factor by CD45: implication in HIV-1 long terminal repeat activation. J. Immunol. 167:2700-13
176. Robichaud GA, Barbeau B, Fortin JF, Rothstein DM, Tremblay MJ. 2002. Nuclear factor of activated T cells is a driving force for preferential productive HIV-1 infection of CD45RO-expressing CD4+ T cells. J. Biol. Chem. 277:23733-41
177. Desmarais S, Jia Z, Ramachandran C. 1998. Inhibition of protein tyrosine phosphatases PTP1B and CD45 by sulfotyrosyl peptides. Arch. Biochem. Biophys. 354:225-31
178. Takakura K, Beckman JS, MacMillan-Crow LA, Crow JP. 1999. Rapid and irreversible inactivation of protein tyrosine phosphatases PTP1B, CD45, and LAR by peroxynitrite. Arch. Biochem. Biophys. 369:197-207
179. Beers SA, Malloy EA, Wu W, Wachter MP, Gunnia U, et al. 1997. Nitroarylhydroxymethylphosphonic acids as inhibitors of CD45. Bioorg. Med. Chem. 5:2203-11
180. Hamaguchi T, Takahashi A, Manaka A, Sato M, OsadaH. 2001. TU-572, a potent and selective CD45 inhibitor, suppresses IgE-mediated anaphylaxis and murine contact hypersensitivity reactions. Int. Arch. Allergy Immunol. 126:318-24
181. Urbanek RA, Suchard SJ, Steelman GB, Knappenberger KS, Sygowski LA, et al. 2001. Potent reversible inhibitors of the protein tyrosine phosphatase CD45. J. Med. Chem. 44:1777-93
182. Nemecek ER, Matthews DC. 2002. Antibody-based therapy of human leukemia. Curr. Opin. Hematol. 9:316-21
183. Zhong RZ, Lazarovits AL. 1998. Monoclonal antibody against CD45RB for the therapy of rejection and autoimmune diseases. J. Mol. Med. 76:572-80
184. Fecteau S, Basadonna GP, Freitas A, Ariyan C, Sayegh MH, Rothstein DM. 2001. CTLA-4 up-regulation plays a role in tolerance mediated by CD45. Nat. Immunol. 2:58-63